We are live on ! Find out more
PALI icon

Palisade Bio

1 hedge funds and large institutions have $11.7M invested in Palisade Bio in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $10.8M → $11.7M (+$835K)

0% more funds holding

Funds holding: 11 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.05M
CS
2
Credit Suisse
Switzerland
$1.58M
Geode Capital Management
3
Geode Capital Management
Massachusetts
$765K
BFA
4
BlackRock Fund Advisors
California
$486K
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$417K
Northern Trust
6
Northern Trust
Illinois
$343K
Fifth Third Bancorp
7
Fifth Third Bancorp
Ohio
$291K
VKH
8
Virtu KCG Holdings
New York
$229K
Morgan Stanley
9
Morgan Stanley
New York
$202K
Bank of New York Mellon
10
Bank of New York Mellon
New York
$153K
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$118K
GT
12
Greenleaf Trust
Michigan
$116K
BRWA
13
B. Riley Wealth Advisors
Florida
$112K
DC
14
Davenport & Co
Virginia
$94.3K
State Street
15
State Street
Massachusetts
$85K
GC
16
Guggenheim Capital
Illinois
$79K
CS
17
Cannell & Spears
New York
$73K
KFS
18
KMS Financial Services
Washington
$60K
AQR Capital Management
19
AQR Capital Management
Connecticut
$55K
LPL Financial
20
LPL Financial
California
$48K
PAG
21
Private Advisor Group
New Jersey
$48K
BA
22
BlackRock Advisors
Delaware
$44K
FWCM
23
First Western Capital Management
California
$44K
U
24
UBS
Switzerland
$31K
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$29K

PALI Hedge Fund Activity: Q4 2013 in Review

1 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2013, worth a combined $11.7M — up 7.7% from $10.8M a quarter earlier.

Fund positioning in PALI was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was DAFNA Capital Management, cutting an estimated $847K.

  • 1 institutional investor held Palisade Bio (PALI) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $11.7M of Palisade Bio stock for Q4 2013, up 7.7% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q4 2013 and 0 closed out.
  • The largest Palisade Bio seller in Q4 2013 was DAFNA Capital Management, an estimated $847K sold.

Based on aggregated 13F filings for Q4 2013.